DESINFEKTIONSRÅDGIVEREN OVE CHRISTOFFERSEN ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.0% 2.5% 2.6% 2.6% 3.5%  
Credit score (0-100)  70 63 61 59 53  
Credit rating  A BBB BBB BBB BBB  
Credit limit (kDKK)  0.3 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  1,382 1,299 1,293 1,114 1,184  
EBITDA  777 677 645 427 521  
EBIT  774 674 642 424 518  
Pre-tax profit (PTP)  703.5 704.8 527.1 461.1 497.7  
Net earnings  547.3 548.2 410.1 358.0 387.5  
Pre-tax profit without non-rec. items  703 705 527 461 498  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Tangible assets total  5.3 2.6 17.2 13.8 10.3  
Shareholders equity total  673 674 536 484 514  
Interest-bearing liabilities  1,332 1,381 571 716 4.8  
Balance sheet total (assets)  2,303 2,349 1,338 1,406 714  

Net Debt  -686 -884 -705 -654 -581  
 
See the entire balance sheet

Volume 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,382 1,299 1,293 1,114 1,184  
Gross profit growth  -3.7% -6.0% -0.5% -13.8% 6.3%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,303 2,349 1,338 1,406 714  
Balance sheet change%  8.3% 2.0% -43.1% 5.1% -49.2%  
Added value  774.2 674.4 642.3 423.6 518.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -5 -5 12 -7 -7  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  56.0% 51.9% 49.7% 38.0% 43.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  35.1% 32.5% 34.8% 36.0% 49.4%  
ROI %  40.5% 37.2% 40.6% 42.7% 60.7%  
ROE %  79.2% 81.4% 67.8% 70.2% 77.7%  

Solidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Equity ratio %  29.2% 28.7% 40.1% 34.5% 71.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -88.4% -130.6% -109.2% -153.2% -111.4%  
Gearing %  198.0% 204.9% 106.5% 147.9% 0.9%  
Net interest  0 0 0 0 0  
Financing costs %  5.9% 3.8% 11.8% 5.2% 7.2%  

Liquidity 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Quick Ratio  1.4 1.4 1.6 1.5 3.5  
Current Ratio  1.4 1.4 1.6 1.5 3.5  
Cash and cash equivalent  2,018.8 2,265.5 1,275.7 1,370.4 585.6  

Capital use efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  644.9 648.2 514.8 468.3 500.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2018/12
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  774 674 642 424 518  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  777 677 645 427 521  
EBIT / employee  774 674 642 424 518  
Net earnings / employee  547 548 410 358 388